Atlas Trials

Spironolactone in Adult Congenital Heart Disease

Clinical trial NCT01069510 · COMPLETED

Trial details

NCT number
NCT01069510
Sponsor
Oregon Health and Science University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Congenital Heart DiseaseHeart FailureEndomyocardial Fibrosis
Start date
2010-02-01
Primary completion
2016-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.